Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

GraniteShares 2x Long NVDA Daily ETFTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

GraniteShares 2x Long NVDA Daily ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $32.91 (market cap $3.52B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 3× GraniteShares 2x Long NVDA Daily ETF's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

NVDLRDY
Market Cap
$3.52B$10.61B
Volume
8,416,4833,738,869
Sector
Leveraged / InverseHealth
52-Week High
$43.02$15.38
52-Week Low
$21.76$11.38
Typical Hold Time
15 Days0 Days
Enterprise Value
—$10.51B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GraniteShares 2x Long NVDA Daily ETF

NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.58 with a 1.81% daily gain. Technical indicators show a bullish overall signal with mixed moving averages and neutral oscillators. The ETF tracks Nvidia's performance with 2x daily leverage, though recent articles highlight it underperformed NVDA's 22.21% one-year return with only 17.21%. Recent news focuses on Nvidia's strong earnings and AI leadership driving optimism.

The outlook remains tied to Nvidia's AI dominance and earnings momentum, offering leveraged exposure to chip sector growth. Key risks include leverage decay, tracking error, and Nvidia's high valuation sensitivity. Investors should weigh the ETF's daily reset mechanism against long-term holding costs amid volatile tech markets.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVDL
68% Buy32% Sell
Avg holding period · 15 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About GraniteShares 2x Long NVDA Daily ETF

NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.

Read more on NVDL →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →